[研究报告] 非明胶空胶囊市场规模预计将从 2022 年的 23.3 亿美元激增至 2030 年的 46.4 亿美元;预计 2022-2030 年期间市场复合年增长率为 9.0%。
分析师观点:
该报告包括当前 非明胶空胶囊市场趋势及其在预测期内可预见的影响所带来的增长前景。近年来,由于人们对素食胶囊选择的认识不断提高,营养保健品和制药公司对非明胶空胶囊的需求量巨大。市场的主要趋势包括产品创新,例如肠溶胶囊、叶绿素胶囊和稳定性和生物利用度更高的胶囊。
药品制造商专注于采购可持续原材料并实施环保生产技术,以满足消费者对环保产品日益增长的需求。产品创新和可持续制造实践是塑造市场的重要趋势。因此,由于对素食和纯素食产品的需求不断增长以及监管支持不断增加,非明胶空心胶囊市场预计将大幅增长。然而,原材料的有限可获得性以及种族和饮食限制也阻碍了非明胶空心胶囊市场的增长。
市场概况:
非明胶空心胶囊广泛用于制药和保健品行业,作为明胶胶囊的替代品。这些胶囊由植物纤维素或淀粉衍生物制成,适合有饮食限制或宗教信仰而禁止食用明胶的人。推动非明胶空心胶囊市场增长的关键因素包括对素食产品的需求不断增长,以及对明胶胶囊缺点的认识不断提高。此外,人们对天然和有机产品的偏好日益增长,以及监管机构在推广非动物产品方面的日益参与,预计将对未来几年非明胶空胶囊市场预测产生重大影响。
定制此报告以满足您的需求
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
- 获取此报告的关键市场趋势。这个免费样品将包括数据分析,从市场趋势到估计和预测。
市场驱动因素:
HPMC 空胶囊在制药行业的使用日益广泛,推动了市场增长
羟丙基甲基纤维素 (HPMC) 胶囊的使用推动了制药行业的扩张。HPMC 空胶囊在药物输送中起着至关重要的作用。HPMC 胶囊具有极强的适应性,这突显了它们适合特定的药物开发需求。它们有不同的尺寸,可以轻松填充 API 剂量,使其用途广泛。这种适应性在竞争激烈的制药行业尤其有用,因为产品的外观和品牌会影响消费者的看法。
HPMC空胶囊用于制药用途已获得欧洲药品管理局(EMA)和美国食品药品管理局(FDA)等监管机构的批准。此项监管批准简化了新药配方的审批流程,为制药公司节省了时间和金钱。
此外,HPMC 空胶囊满足了日益增长的清洁标签商品和药物市场的需求,因此非常适合素食者或纯素食者。对于旨在满足客户多样化需求的制药公司来说,这一考虑至关重要。HPMC 空胶囊的出色性能进一步使制药行业受益。由于其更高的稳定性,这些胶囊可以保护其所含药物免受空气和湿气等污染物的影响。更长的保质期对制药公司来说至关重要,因为它可以保证药物在长期内持续有效和安全。此外,HPMC 空胶囊具有良好的溶解性能,可以提高某些药物的生物利用度,从而带来更成功的治疗效果。HPMC 的这些特性推动了对非明胶空胶囊的需求。
节段分析:
非明胶空胶囊市场分析是通过考虑以下几个部分来进行的:类型、应用和最终用户。
根据类型,非明胶空胶囊市场细分为 HPMC 胶囊和普鲁兰胶囊。HPMC胶囊细分市场在 2022 年占据了更大的市场份额。普鲁兰胶囊细分市场预计在 2022-2030 年期间的复合年增长率将达到 9.9%。人们对动物产品过敏的担忧日益加剧,推动了对非明胶胶囊的需求。HPMC 胶囊源自植物纤维素,具有出色的稳定性和灵活性。将药物装入植物胶囊中可形成一种有吸引力的、完全天然的剂型,具有易于吞咽、有效掩盖味道和气味以及产品可见性等优点。这些胶囊还不含淀粉、麸质和防腐剂,可满足选择素食生活方式的客户的严格营养需求。此外,越来越多的纯素食者和素食者更喜欢植物替代品,例如 HPMC 胶囊。
根据应用,市场分为抗生素和抗菌药物、维生素和膳食补充剂、抗酸药和抗胀气制剂等。抗生素和抗菌药物部分在 2022 年占据了最大的非明胶空心胶囊市场份额。维生素和膳食补充剂部分市场预计将在 2022-2030 年期间以 9.9% 的最快复合年增长率增长。传染病病例的增加、中低收入国家对抗生素的需求不断增长以及主要制药公司在研发方面的投资激增是推动抗生素和抗菌制造和包装设施对非明胶空心胶囊需求的关键因素。
非明胶空胶囊用于制药行业封装药物和营养补充剂,确保剂量精确和控制释放。此外,维生素和补充剂市场的增长归因于对治疗药物的不断增长的需求以及营养补充剂越来越受欢迎,以改善健康结果。补充剂行业封装维生素、矿物质和草药提取物,以便于食用、有针对性地递送和提高有效性。
根据最终用户,非明胶空心胶囊市场分为制药行业、营养保健品行业、化妆品行业和研究实验室。制药行业在 2022 年占据了最大的非明胶空心胶囊市场份额。预计在 2022-2030 年期间,该行业将实现 9.4% 的最高复合年增长率。HPMC 胶囊已获得欧洲药品管理局 (EMA) 和美国食品药品管理局 (FDA) 等监管机构的批准,可用于制药目的。法规合规性是制药公司确保其产品安全性和有效性的首要任务。这些组织接受 HPMC 胶囊简化了新药配方的审批流程,并为最终产品的安全性提供了一定的保障。因此,随着人们对纯素和素食药物的需求不断增长,制药行业的扩张促进了非明胶空心胶囊市场的增长。
区域分析:
非明胶空心胶囊市场报告的地理范围包括北美、欧洲、亚太地区、中东和非洲以及南美和中美洲。2022 年北美市场价值为 6.3 亿美元,预计到 2030 年将达到 12.8 亿美元;预计 2022-2030 年复合年增长率为 9.2%。北美非明胶空心胶囊市场分为美国、加拿大和墨西哥。推动该地区市场增长的关键因素之一是素食和纯素食生活方式的接受度越来越高。因此,各个行业对草药替代品的需求日益增长,包括药品、营养保健品和膳食补充剂。非明胶空胶囊是封装营养保健品和膳食补充剂的热门选择,因为它们提供了一种方便有效的方式将活性成分输送到体内。美国拥有成熟的营养保健品市场。该国消费的主要膳食补充剂包括复合维生素、钙和维生素 D 补充剂以及 omega-3 脂肪酸。这些补充剂的消费是由老龄化人口推动的,与前几代人相比,老龄化人口更关心健康老龄化。此外,对预防与年龄相关的疾病的膳食补充剂的需求将对北美的非明胶空胶囊市场产生积极影响。
预计亚太市场将在全球非明胶空心胶囊市场中创下最快的复合年增长率。该地区,尤其是印度和中国等国家,拥有规模庞大的制药业。中国是制药制造中心。该地区预计的市场增长归因于该地区拥有功能齐全的制造单位和合同制造设施。此外,医疗保健系统引入战略来实施预防措施以获得积极的治疗效果,这促进了中国非明胶空心胶囊市场的增长。此外,印度和其他国家大多数人口的文化信仰表明他们倾向于使用非明胶胶囊。
非明胶空胶囊市场区域洞察
Insight Partners 的分析师已详尽解释了预测期内影响非明胶空胶囊市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的非明胶空胶囊市场细分和地理分布。
- 获取非明胶空胶囊市场的区域具体数据
非明胶空胶囊市场报告范围
报告属性 | 细节 |
---|---|
2022 年市场规模 | 23.3亿美元 |
2030 年的市场规模 | 46.4 亿美元 |
全球复合年增长率(2022 - 2030 年) | 9.0% |
史料 | 2020-2022 |
预测期 | 2022-2030 |
涵盖的领域 | 按类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
非明胶空胶囊市场参与者密度:了解其对业务动态的影响
非明胶空胶囊市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。
在非明胶空胶囊市场运营的主要公司有:
- 龙沙集团 (Capsugel)
- 三菱化学控股公司(Qualicaps, Inc.)
- 艾拉瓦特制药有限公司
- ACG 全球
- 苏兴胶囊
免责声明:上面列出的公司没有按照任何特定顺序排列。
- 了解非明胶空胶囊市场主要参与者概况
关键球员分析:
LonzaGroup(Capsugel)、三菱化学控股公司(Qualicaps, Inc.)、Erawat Pharma Limited、ACG Worldwide、Suheung Capsule、Sunil Healthcare、CapsCanada Corporation、BrightCaps GmbH、Natural Capsules Limited 和 Healthcaps India Limited 是非明胶空胶囊市场报告中介绍的主要参与者。
最新动态:
非明胶空心胶囊市场中的公司采用并购作为主要增长战略。以下列出了一些近期的市场发展情况:
- 2023 年 3 月,ACG 公司 VANTAGE NUTRITION 收购了 ComboCap, Inc.(美国)和 BioCap(南非),以增强其技术专长并扩大其在北美和全球的影响力。
- 2022 年 1 月,西安乐纽特配料有限公司向欧洲拉脱维亚运送了 800 万粒 HPMC 胶囊。这些胶囊不含二氧化钛 (TiO2),因为欧盟委员会已禁止在食品添加剂中使用 TiO2。这凸显了该公司为满足该地区对具有特定监管规范的产品的需求而做出的努力。
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The factors driving the growth of the non-gelatin empty capsules market include the increasing use of HPMC empty capsules in the pharmaceutical industry and proliferating nutraceuticals industry.
The non-gelatin empty capsules market majorly consists of the players such as LonzaGroup (Capsugel), Mitsubishi Chemical Holdings Corporation (Qualicaps, Inc.), Erawat Pharma Limited, ACG Worldwide, Suheung Capsule, Sunil Healthcare, CapsCanada Corporation, BrightCaps GmbH, Natural Capsules Limited, Healthcaps India Limited.
The non-gelatin empty capsules market is expected to be valued at US$ 4.64 billion in 2030.
The global non-gelatin empty capsules market, based on type, the non-gelatin empty capsules market is divided into HPMC capsules and pullulan capsules. The HPMC capsules segment held a larger market share in 2022. The pullulan capsules segment is said to register a higher CAGR of 9.9% during 2022–2030. Based on application, the non-gelatin empty capsules market is segmented into antibiotic and antibacterial drugs, vitamins and dietary supplements, antacids and antiflatulent preparations, and others. The antibiotic and antibacterial drugs segment held the largest market share in 2022. The market for the vitamins and dietary supplements segment is estimated to grow at the fastest CAGR of 9.9% during 2022–2030. In terms of end user, the market segmented into pharmaceutical industry, nutraceutical industry, cosmetics industry, and research laboratories. The pharmaceutical industry segment accounted for the largest non-gelatin empty capsules market share in 2022. The same segment is anticipated to register the highest CAGR of 9.4% during 2022–2030.
The non-gelatin empty capsules market was valued at US$ 2.33 billion in 2022.
Non-gelatin empty capsules are widely used in the pharmaceutical and nutraceutical industries as an alternative to gelatin capsules. These capsules are made from plant cellulose or starch derivatives, making them suitable for people with dietary restrictions or religious beliefs that prohibit the consumption of gelatin. Furthermore, the surging preference for natural and organic products, and the increasing involvement of regulatory bodies in promoting non-animal products are likely to favor the non-gelatin empty capsules market in the future.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Non-Gelatin Empty Capsules Market
- LonzaGroup (Capsugel)
- Mitsubishi Chemical Holdings Corporation (Qualicaps, Inc.)
- Erawat Pharma Limited
- ACG Worldwide
- Suheung Capsule
- Sunil Healthcare
- CapsCanada Corporation
- BrightCaps GmbH
- Natural Capsules Limited
- Healthcaps India Limited
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.